Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Like
Tweet
Print
Lia Tzala
Amgen Ltd, Uxbridge, United-Kingdom, United Kingdom
Poster(s):
(011) Characteristics and treatment sequences of patients with KRAS G12C, other KRAS and KRAS-wild-type advanced or metastatic (AM) Non-Small Cell Lung Cancer (NSCLC) in the French ESME cohort
Tuesday, August 27, 2024
8:00 AM – 6:00 PM
CEST
